Supergroup
Vaccine vs COVID - Common Discussion of COVID-19 Vaccines |Pfizer Moderna CureVac Novavax AstraZeneca Janssen Sanofi-GSK Valneva
@vaccine_vs_covid
On this record: Growth · Cite this entry
113members
+6 since we began measuring on 6 August 2026
12 online right now
The groups register · The largest groups, measured directly.
Register entry
| Type | Supergroup |
|---|---|
| Username | @vaccine_vs_covid |
| First recorded | 6 August 2026 |
| Last confirmed live | 15 September 2026 |
| Measurements held | 5 |
| Confirmed unchanged | 2 times, most recently 15 September 2026 |
| On Telegram | t.me/vaccine_vs_covid |
Member counts are read from the group’s own public profile page — the same t.me/<name> surface a channel’s count is read from, printed in full rather than short-formed. See how we measure.
Growth
| Measured (UTC) | Members | Change |
|---|---|---|
| 7 Sept 2026, 16:19 | 113 | +6 |
| 28 Aug 2026, 17:53 | 107 | -1 |
| 21 Aug 2026, 16:12 | 108 | -1 |
| 13 Aug 2026, 15:57 | 109 | +2 |
| 6 Aug 2026, 23:55 | 107 | first reading |
Cite this entry
A live page changes as we take new readings, so a citation should name the measurement it is based on, not just the URL. The line below cites the member count as measured 7 September 2026 — this entry's latest reading, not the date you are reading this.
“Vaccine vs COVID - Common Discussion of COVID-19 Vaccines |Pfizer Moderna CureVac Novavax AstraZeneca Janssen Sanofi-GSK Valneva” (@vaccine_vs_covid), 113 members as measured 7 September 2026. Telegram Register, tgregister.com/group/vaccine_vs_covid.